載入中
HKSEHealthcareMedical - Care Facilities
最新資料
HK$0.69
−HK$0.01 · -1.43%
Concord Healthcare Group Co., Ltd. is dedicated to providing comprehensive cancer treatment services for patients and healthcare institutions throughout China. Its operations extend beyond direct care to include the distribution and installation of medical hardware and software, along with offering management and technical assistance, and providing equipment via operating leases. The company was founded in 2008 and is headquartered in Beijing, China. It functions as a subsidiary of Shanghai Medstar Financial Leasing Company.
最新資料
HK$0.69
−HK$0.01 · -1.43%
盤中時間採用HKT。市場資料可能有所延遲。
Concord Healthcare Group Co., Ltd. is dedicated to providing comprehensive cancer treatment services for patients and healthcare institutions throughout China. Its operations extend beyond direct care to include the distribution and installation of medical hardware and software, along with offering management and technical assistance, and providing equipment via operating leases. The company was founded in 2008 and is headquartered in Beijing, China. It functions as a subsidiary of Shanghai Medstar Financial Leasing Company.
日內區間
目前HK$0.69
52週區間
目前HK$0.69
盤中時間採用HKT。市場資料可能有所延遲。
Concord Healthcare Group Co., Ltd. is dedicated to providing comprehensive cancer treatment services for patients and healthcare institutions throughout China. Its operations extend beyond direct care to include the distribution and installation of medical hardware and software, along with offering management and technical assistance, and providing equipment via operating leases. The company was founded in 2008 and is headquartered in Beijing, China. It functions as a subsidiary of Shanghai Medstar Financial Leasing Company.
日內區間
目前HK$0.69
52週區間
目前HK$0.69
獲利能力占已公布營收的百分比。
營收
營業利益
淨利
| 項目（CNY） | 2025會計年度 | 2024會計年度 | 2023會計年度 | 2022會計年度 | 2021會計年度 |
|---|---|---|---|---|---|
| 營收 | 4.48億 CNY | 3.88億 CNY | 5.39億 CNY | 4.72億 CNY | 4.71億 CNY |
| 銷貨成本 | 4.17億 CNY | 4.56億 CNY | 6.04億 CNY | 7.47億 CNY | 6.6億 CNY |
| 毛利 | 3112.31萬 CNY | −6724.8萬 CNY | −6508.9萬 CNY | −1.97億 CNY | −9275.54萬 CNY |
| 研究與開發 | 2744.29萬 CNY | 3118.4萬 CNY | 3644.3萬 CNY | 4131.6萬 CNY | 4038.1萬 CNY |
| 銷售、一般及管理費用 | 1.87億 CNY | 2.59億 CNY | 2.53億 CNY | 2.74億 CNY | 1.03億 CNY |
| 營業費用 | 2.63億 CNY | 3.3億 CNY | 2.89億 CNY | 3.59億 CNY | 3.76億 CNY |
| 利息收入 | 65.85萬 CNY | 73.3萬 CNY | 728.1萬 CNY | 778.6萬 CNY | 546.7萬 CNY |
| 利息支出 | 1.2億 CNY | 1.09億 CNY | 1.08億 CNY | 2.74億 CNY | 4.35億 CNY |
| 折舊和攤銷 | 1.53億 CNY | 1.14億 CNY | 1.52億 CNY | 1.48億 CNY | 1.14億 CNY |
| 營業利益 | −2.32億 CNY | −3.71億 CNY | −3.54億 CNY | −4.78億 CNY | −3.93億 CNY |
| 淨利 | −2.5億 CNY | −4.43億 CNY | −3.73億 CNY | −5.41億 CNY | −8.17億 CNY |
公司資料更新於 2026年10月14日。
已公布業績及可用的市場共識預估。
已公布業績及可用的市場共識預估。
AI 生成內容及延遲市場資料僅供資訊與教育用途，不構成投資建議。
